Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 5, 2006

View Archived Issues

NanoViricides updates corporate strategy

StemCells and Stem Cell Therapeutics enter license agreement

Array BioPharma presents a new antibacterial agent with activity against MRSA

CE Mark for NeoVisc viscosupplementation therapy

Curis to opt out of codevelopment of basal cell carcinoma drug candidate

Glypromate to be studied in reducing brain injury from cardiac arrest

Phase I study of prime-boost vaccine shows T-cell immunity against HIV

Selective CYP11B2 inhibitors reported for the treatment of heart diseases

New antibacterial agents disclosed in recent patent literature

New therapeutic agents for cancer imparted in recent patents

Cardioprotective effects of a new selective NHE-1 inhibitor

alpha-MSH backbone cyclic peptide as a new antiobesity candidate

New agents for urinary incontinence disclosed in recent Norgine patent

Samaritan and Georgetown University jointly disclose novel agents for HIV infection

Cyclin A2 induces myocardial regeneration and facilitates recovery following ischemic heart failure

Clinical evaluation of carmoterol in asthma

Rapinyl filed for breakthrough cancer pain in Europe

Sativex filed in selected European countries for MS spasticity

Clinical evaluation of tetomilast in chronic obstructive pulmonary disease

Orencia available in Canada

Sitaxsentan improves hemodynamics and exercise capacity in patients with PAH

Beneficial effects of curcumin against endothelial inflammation in atherogenesis

MabThera indications extended in U.K.

Baraclude launched in U.K.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...